Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Md Sayeed Akhtar, Md Quamrul Hassan, Aisha Siddiqui, Sirajudeen S. Alavudeen, Obaid Afzal, Abdulmalik S.A Altamimi, Syed Obaidur Rahman, Mallika Khurana, Mohamed Jawed Ahsan, Arun Kumar Sharma & Fauzia Tabassum. (2023) Levosimendan: mechanistic insight and its diverse future aspects in cardiac care. Acta Cardiologica 78:2, pages 170-187.
Read now
Read now
Maryam Armandeh, Behnaz Bameri, Maryam Baeeri, Hamed Haghi-Aminjan, Mahban Rahimifard, Shokoufeh Hassani, Mohammad Reza Hooshangi Shayesteh, Madiha Khalid, Mahedeh Samadi, Rohollah Hosseini, Majid Masoudi Fard & Mohammad Abdollahi. (2021) The role of levosimendan in phosphine-induced cardiotoxicity: evaluation of electrocardiographic, echocardiographic, and biochemical parameters. Toxicology Mechanisms and Methods 31:9, pages 631-643.
Read now
Read now
Articles from other publishers (10)
Andreas Boening, Edgar Welk, Martina Heep, Carina Hemmerich, Bernd Niemann, Klaus-Dieter Schlüter & Zulfugar T Taghiyev. (2022) Oral application of levosimendan before ischaemia/reperfusion with or without cardioplegic arrest in rats. European Journal of Cardio-Thoracic Surgery 62:4.
Crossref
Crossref
Vasileios Leivaditis, Efstratios Koletsis, Nikolaos Tsopanoglou, Nikolaos Charokopos, Cristian D’Alessandro, Konstantinos Grapatsas, Efstratios Apostolakis, Effrosyni Choleva, Maria Plota, Andreas Emmanuil, Manfred Dahm & Dimitrios Dougenis. (2022) The Coadministration of Levosimendan and Exenatide Offers a Significant Cardioprotective Effect to Isolated Rat Hearts against Ischemia/Reperfusion Injury. Journal of Cardiovascular Development and Disease 9:8, pages 263.
Crossref
Crossref
Ling-Li Li, Li Wei, Ning Zhang, Wen-Ying Wei, Can Hu, Wei Deng & Qi-Zhu Tang. (2020) Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway. BioMed Research International 2020, pages 1-11.
Crossref
Crossref
Abeer M. Rababa'h, Karem H. Alzoubi, Sandy Baydoun & Omar F. Khabour. (2020) Levosimendan Prevents Memory Impairment Induced by Diabetes in Rats: Role of Oxidative Stress. Current Alzheimer Research 16:14, pages 1300-1308.
Crossref
Crossref
Mustafa Sitki Gozeler, Fazile Nur Ekinci Akdemir, Serkan Yildirim, Abdulkadir Sahin, Gizem Eser & Seda Askin. (2019) Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model. International Journal of Pediatric Otorhinolaryngology 122, pages 70-75.
Crossref
Crossref
Fei Yang, Li Na Zhao, Yi Sun & Zhuang Chen. (2019) Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. Journal of International Medical Research 47:5, pages 1817-1828.
Crossref
Crossref
Ferhat Kalkan, Hakan Parlakpinar, Olcay M. Disli, Lokman H. Tanriverdi, Onural Ozhan, Alaaddin Polat, Aslı Cetin, Nigar Vardi, Yılmaz O. Otlu & Ahmet Acet. (2018) Protective and therapeutic effects of dexpanthenol on isoproterenol‐induced cardiac damage in rats. Journal of Cellular Biochemistry 119:9, pages 7479-7489.
Crossref
Crossref
Juan Gao, Min Zhu, Rui-Feng Liu, Jian-Shu Zhang & Ming Xu. (2018) Cardiac Hypertrophy is Positively Regulated by MicroRNA-24 in Rats. Chinese Medical Journal 131:11, pages 1333-1341.
Crossref
Crossref
Mengting Sheng, Zirui Huang, Liming Pan, Min Yu, Cai Yi, Lin Teng, Ling He, Chen Gu, Chunli Xu & Junming Li. (2017) SOCS2 exacerbates myocardial injury induced by ischemia/reperfusion in diabetic mice and H9c2 cells through inhibiting the JAK-STAT-IGF-1 pathway. Life Sciences 188, pages 101-109.
Crossref
Crossref
Udo Boeken, Moritz Benjamin Immohr, Alexander Jenke, Annika Jahn, Laura Dohrn, Markus Kornfeld, Antonio Pinto, Artur Lichtenberg & Payam Akhyari. (2017) CARDIAC-Exploring the Pleiotropic Effects of Levosimendan – Impact on Systemic Inflammatory Parameters and Molecular Salvage Path-ways by Modulation of Cytokine Levels and Tissue Apoptosis Rate. Journal of Heart and cardiology 3:1, pages 1-9.
Crossref
Crossref